-
Transitioning from preclinical to clinical development is a critical step in drug development, often accompanied by significant challenges. This webinar will explore key considerations from a clinical pharmacology perspective, and explore potential solutions to establish a robust plan for your First-In-Human study.
Key learnings:
• Key elements in the transition from preclinical to clinical
• How the target population shapes FIH trials for your drug
• Understanding the role of drug-drug interactions in the early clinical development of your drug
• Handling unexpected pharmacokinetic results in your first-in-human study
#Drugdevelopment
Click here to register